Read the latest news from Northwestern University Feinberg School of Medicine’s Department of Pediatrics and Ann & Robert H. Lurie Children’s Hospital of Chicago. The links below take you to articles where you can learn more about our faculty’s latest achievements, awards and honors.
Investigators have discovered striking genetic differences in subsets of fetal immune cells, providing insight into morbidity related to premature birth.
Northwestern Medicine investigators have continued to examine COVID-19, from the impact of prone positioning during treatment to vaccine protection against the Omicron variant in children.
- First Potential Immunization Against RSV for Healthy Infants Found Highly Effective in Phase 3 Trial03.09.2022
A new drug has been shown to be highly effective against pediatrics infections caused by respiratory syncytial virus (RSV).
Northwestern Medicine investigators continue to study the COVID-19 pandemic, from the biological mechanisms of disease and infection patterns to the pandemic’s impact on women and sexual and gender minorities.
A novel gene therapy promoted transfusion independence in more than 90 percent of adult and pediatric patients with transfusion-dependent beta-thalassemia, according to a recent clinical trial published in The New England Journal of Medicine.
The laboratory of YouYang Zhao, PhD, developed a unique nanoparticle to deliver genome editing technology, including CRISPR/Cas9, to vascular endothelial cells.
Living in U.S. counties with higher concentrations of poverty was associated with increased risk of firearm-related deaths among children and young adults, according to a recent study.
On November 5, students in the Master of Prosthetics & Orthotics (MPO) program through Northwestern’s Prosthetics-Orthotics Center constructed more than 50 braces for teddy bears gifted to pediatric patients at Ann & Robert H. Lurie Children’s Hospital.
Ann & Robert H. Lurie Children’s Hospital of Chicago has recruited an internationally recognized surgeon-scientist, Thomas H. Inge, MD, PhD, as the hospital’s next surgeon-in-chief.
Tisagenlecleucel, a chimeric antigen receptor (CAR) T-cell immunotherapy, demonstrated safety and efficacy in pediatric patients with relapsed and refractory B-cell acute lymphoblastic leukemia, according to recent findings.
Northwestern Medicine scientists have characterized several variants of the gene GRIK2 that cause nonsyndromic neurodevelopmental disorder.
Children born to women with epilepsy who took anti-seizure medications during pregnancy versus children born to women without epilepsy did not differ in terms of cognitive outcomes and overall neurodevelopment, according to findings published in JAMA Neurology.